Belgian biopharmaceutical company Cardio3 Biosciences, which is backed by a consortium of venture capital firms, has announced that it is considering listing new shares in an IPO.
Talis Capital joins the round alongside existing investors including Speedinvest
Healthcare workforce management software company has expanded internationally under Hg's tenure
Consortium of backers invest €3.7m in the French note-taking app developer
Fresh capital will be used to scale up the company's engineering and research and development teams